297 filings
Page 8 of 15
4
hauqxx10248n775 2s
21 Jun 22
Immunome / Corleen M. Roche ownership change
6:06pm
4
bey08n8eze 8jiu4olo
21 Jun 22
Immunome / MATTHEW K ROBINSON ownership change
6:06pm
4
csqnorgtm nm5p8devz
21 Jun 22
Immunome / Dennis H Giesing ownership change
6:05pm
4
dwdfpv ik830b
21 Jun 22
Immunome / PHILIP WAGENHEIM ownership change
6:04pm
4
oevmj85tlha38u3p0 g2
21 Jun 22
Immunome / MICHAEL RAPP ownership change
6:04pm
4
6tj6bjze282s
21 Jun 22
Immunome / FRANKLYN G PRENDERGAST ownership change
6:03pm
4
0271zjqcyept xg
21 Jun 22
Immunome / Michael Lefenfeld ownership change
6:02pm
4
60x3za3 06h8jb
21 Jun 22
Immunome / JOHN L LAMATTINA ownership change
6:01pm
4
qna fzlle
21 Jun 22
Immunome / RICHARD A BARON ownership change
6:01pm
3
g1enivfo
21 Jun 22
Immunome / MATTHEW K ROBINSON ownership change
6:00pm
8-K
9xfghs3g0cuzu1hja6
17 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
m24l2spo 934c3
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
8-K
32m5jfg104ycg
19 May 22
Other Events
4:05pm
8-K
9bpwmq8hblj9066ee9d3
12 May 22
Immunome Reports First Quarter 2022 Financial Results
8:34am
DEFA14A
gyhqnay2yaag9 5s8xt
29 Apr 22
Additional proxy soliciting materials
4:40pm
8-K
hx2ixvjuyfk24 wnjj
28 Mar 22
Immunome Reports Fourth Quarter and Full Year 2021 Financial Results
8:14am
8-K
hi6oxcw 08
11 Mar 22
FDA Lifts Clinical Hold on Immunome’s IMM-BCP-01 IND Application for the Treatment of COVID-19
2:33pm